Information for Clinicians
New guidelines for oral contraception:
- Effective from 1st January 2014.
- Oestrogen and/ or progestogens taken between evacuation of the mole and the return to normality of hCG values appear not to increase the risk of invasive mole or choriocarcinoma developing. Therefore women may use oral contraceptives after molar evacuation, before the hCG returns to normal.
Patient registrationPatient registration for tumour marker monitoring of hydatidiform moles is now available online. UK gynaecologists registering women with one of the specialist centres (Dundee, London or Sheffield) for this disease should use the NHSnet online form. This website provides a secure system complying with DH standards and the Data Protection Act 1998.
|The address for registering patients is https://nww.h-mole.nhs.uk NHS net only (opens in a new window).|
NB This site is external to the Sheffield Trophoblastic Disease Centre. If you have any problems please email email@example.com If still having problems ring 0203 311 5555
If you are unable to register online you can fax the paper form to 0114 226 5511 or email this electronic version (Excel) to Trophoblastic@sth.nhs.uk
Contact information for the other UK Centres
A guide to management practices at Weston Park HospitalThe booklet Gestational Trophoblastic Neoplasia: A guide to management at Weston Park Hospital provides a guide for all clinicians concerned with the management of patients with Gestational Trophoblastic Disease (GTD) at Weston Park Hospital (WPH), Sheffield Teaching Hospitals NHS Trust (STHFT).
This booklet was revised 20th January 2014.